Patent · US Active

Inhibitors of integrated stress response pathway

US11230542B2 · kind B2 · utility

0Cited by
1References
58Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2018
Grant dateJan 25, 2022
Priority date—
Expiry dateDec 13, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2500/32
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to therapeutic agents that may be useful as inhibitors of Integrated Stress Response (ISR) pathway.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.